By Foo Yun Chee
作者：Foo Yun Chee
Brussels, June 26 (Reuters) - France-Based Cooper Consumer Health on Wednesday Secured EU Antitrust Approval to Buy U.S. Drugmaker Viatris' Vtrs.o European Over-the-Counter Drug Business After Agreeing to Sell Its Rights and Interests in an Infant Laxative Medicine and Earwax Removal Product.
法國Cooper消費健康公司於週三獲得了歐盟反壟斷部門的批准，以購買美國製藥公司Viatris的業務。Vtrs.o同意出售其嬰兒瀉藥和耳垢清潔產品的權利和利益後，獲得歐洲非處方藥業務。
The Companies Announced the $3.6 Billion Deal Last October, With Viatris Selling Some of Its Businesses to Focus on Ophthalmology, Gastroenterology and Dermatology.
這兩家公司於去年10月宣佈了這筆價值36億美元的交易。交易Viatris出售了一些業務，以便專注於眼科醫療，胃腸病和皮膚科。
The European Commission, Which Acts as the EU Competition Enforcer, Said Cooper's Concessions Came After It Voiced Concerns About the High Combined Market Shares as a Result of the Deal and Also Insufficient Competitive Pressure From Rivals.
歐盟委員會是歐盟競爭執行機構，稱Cooper所提出的讓步是在其對該交易所形成的高市場份額和競爭壓力不足表達關切之後做出的。
Cooper Will Divest Its Rights, Title and Interests in Its Infant Laxative Medicine Bebegel and Its Rights, Title and Interests in Its Earwax Removal Product Otowaxol to Address the Commission's Competition Concerns, the EU Watchdog Said.
歐盟監管機構表示，Cooper將放棄其嬰兒泄瀉藥Bebegel的權利，所有權和利益以及其耳垢清潔產品Otowaxol的權利，所有權和利益，以解決委員會的競爭擔憂。
"the Remedies Offered by Viatris and Cooper Will Ensure That Competition on These Markets Remains Effective and That, Ultimately, Consumers in Portugal and Germany Do Not End up Paying Higher Prices for Certain Pharmaceutical Products," EU Antitrust Chief Margrethe Vestager Said.
歐盟反壟斷主管Margrethe Vestager稱:"Viatris和Cooper提供的補救措施將確保這些市場上的競爭仍然有效，並且最終，葡萄牙和德國的消費者不會爲某些藥品支付更高的價格。"
Viatris Was Formed Through the Merger of Mylan and Pfizer Inc's Pfe.n Upjohn Business and Deals With Generic and Key Branded Drugs in Its Portfolio, Including Arthritis Treatment Celebrex, Erectile Dysfunction Drug Viagra, Epilepsy Treatment Lyrica, and Antidepressant Zoloft.
Viatris是由邁蘭和輝瑞公司的Upjohn業務合併而成，其組合中包括非專利藥和重要品牌藥物，包括關節炎治療Celebrex，勃起功能障礙藥物Viagra，癲癇治療Lyrica和抗抑鬱藥Zoloft。Pfe.nUpjohn業務涉及其組合中的通用藥品和主要品牌藥品，包括關節炎治療Celebrex、勃起功能障礙藥物Viagra、癲癇治療Lyrica和抗抑鬱藥物Zoloft。
(Reporting by Foo Yun Chee)
（報道作者:付雲翀）
((Foo.yunchee@Thomsonreuters.com; +32 2 585 2866; Reuters Messaging: Foo.yunchee.thomsonreuters.com@Reuters.net))
((Foo.yunchee@thomsonreuters.com; +32 2 585 2866; Reuters通訊:foo.yunchee.thomsonreuters.com@reuters.net))